685 related articles for article (PubMed ID: 18809732)
1. Design, data analysis, and simulation of in vitro drug transport kinetic experiments using a mechanistic in vitro model.
Poirier A; Lavé T; Portmann R; Brun ME; Senner F; Kansy M; Grimm HP; Funk C
Drug Metab Dispos; 2008 Dec; 36(12):2434-44. PubMed ID: 18809732
[TBL] [Abstract][Full Text] [Related]
2. Mechanistic modeling of hepatic transport from cells to whole body: application to napsagatran and fexofenadine.
Poirier A; Funk C; Scherrmann JM; Lavé T
Mol Pharm; 2009; 6(6):1716-33. PubMed ID: 19739673
[TBL] [Abstract][Full Text] [Related]
3. Substrate-dependent drug-drug interactions between gemfibrozil, fluvastatin and other organic anion-transporting peptide (OATP) substrates on OATP1B1, OATP2B1, and OATP1B3.
Noé J; Portmann R; Brun ME; Funk C
Drug Metab Dispos; 2007 Aug; 35(8):1308-14. PubMed ID: 17470528
[TBL] [Abstract][Full Text] [Related]
4. Prediction of pharmacokinetic profile of valsartan in humans based on in vitro uptake-transport data.
Poirier A; Cascais AC; Funk C; Lavé T
Chem Biodivers; 2009 Nov; 6(11):1975-87. PubMed ID: 19937834
[TBL] [Abstract][Full Text] [Related]
5. Kinetic determinants of hepatic clearance: plasma protein binding and hepatic uptake.
Baker M; Parton T
Xenobiotica; 2007; 37(10-11):1110-34. PubMed ID: 17968739
[TBL] [Abstract][Full Text] [Related]
6. Decrease in intracellular concentration causes the shift in Km value of efflux pump substrates.
Korjamo T; Kemiläinen H; Heikkinen AT; Mönkkönen J
Drug Metab Dispos; 2007 Sep; 35(9):1574-9. PubMed ID: 17548462
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of transporter-mediated hepatic uptake in a non-radioactive high-throughput assay: a study of kinetics, species difference and plasma protein effect.
Li L; Nouraldeen A; Wilson AG
Xenobiotica; 2013 Mar; 43(3):253-62. PubMed ID: 22928802
[TBL] [Abstract][Full Text] [Related]
8. Estimating human drug oral absorption kinetics from Caco-2 permeability using an absorption-disposition model: model development and evaluation and derivation of analytical solutions for k(a) and F(a).
Usansky HH; Sinko PJ
J Pharmacol Exp Ther; 2005 Jul; 314(1):391-9. PubMed ID: 15833900
[TBL] [Abstract][Full Text] [Related]
9. Prediction of human pharmacokinetics - renal metabolic and excretion clearance.
Fagerholm U
J Pharm Pharmacol; 2007 Nov; 59(11):1463-71. PubMed ID: 17976256
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic drug interaction between fexofenadine and fluvastatin mediated by organic anion-transporting polypeptides in rats.
Qiang F; Lee BJ; Lee W; Han HK
Eur J Pharm Sci; 2009 Jun; 37(3-4):413-7. PubMed ID: 19428223
[TBL] [Abstract][Full Text] [Related]
11. Prediction of the pharmacokinetics of atorvastatin, cerivastatin, and indomethacin using kinetic models applied to isolated rat hepatocytes.
Paine SW; Parker AJ; Gardiner P; Webborn PJ; Riley RJ
Drug Metab Dispos; 2008 Jul; 36(7):1365-74. PubMed ID: 18426955
[TBL] [Abstract][Full Text] [Related]
12. Prediction of human pharmacokinetics--gastrointestinal absorption.
Fagerholm U
J Pharm Pharmacol; 2007 Jul; 59(7):905-16. PubMed ID: 17637184
[TBL] [Abstract][Full Text] [Related]
13. Mechanistic pharmacokinetic modeling for the prediction of transporter-mediated disposition in humans from sandwich culture human hepatocyte data.
Jones HM; Barton HA; Lai Y; Bi YA; Kimoto E; Kempshall S; Tate SC; El-Kattan A; Houston JB; Galetin A; Fenner KS
Drug Metab Dispos; 2012 May; 40(5):1007-17. PubMed ID: 22344703
[TBL] [Abstract][Full Text] [Related]
14. Prediction of pharmacokinetic profile of valsartan in human based on in vitro uptake transport data.
Poirier A; Cascais AC; Funk C; Lavé T
J Pharmacokinet Pharmacodyn; 2009 Dec; 36(6):585-611. PubMed ID: 19936896
[TBL] [Abstract][Full Text] [Related]
15. Uptake of rosuvastatin by isolated rat hepatocytes: comparison with pravastatin.
Nezasa K; Higaki K; Takeuchi M; Nakano M; Koike M
Xenobiotica; 2003 Apr; 33(4):379-88. PubMed ID: 12745873
[TBL] [Abstract][Full Text] [Related]
16. Permeability, transport, and metabolism of solutes in Caco-2 cell monolayers: a theoretical study.
Sun H; Pang KS
Drug Metab Dispos; 2008 Jan; 36(1):102-23. PubMed ID: 17932224
[TBL] [Abstract][Full Text] [Related]
17. Kinetic characterization of rat hepatic uptake of 16 actively transported drugs.
Yabe Y; Galetin A; Houston JB
Drug Metab Dispos; 2011 Oct; 39(10):1808-14. PubMed ID: 21730030
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of oat3-mediated renal uptake as a mechanism for drug-drug interaction between fexofenadine and probenecid.
Tahara H; Kusuhara H; Maeda K; Koepsell H; Fuse E; Sugiyama Y
Drug Metab Dispos; 2006 May; 34(5):743-7. PubMed ID: 16455804
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous assessment of uptake and metabolism in rat hepatocytes: a comprehensive mechanistic model.
Ménochet K; Kenworthy KE; Houston JB; Galetin A
J Pharmacol Exp Ther; 2012 Apr; 341(1):2-15. PubMed ID: 22190645
[TBL] [Abstract][Full Text] [Related]
20. Theoretical investigation of passive intestinal membrane permeability using Monte Carlo method to generate drug-like molecule population.
Sugano K
Int J Pharm; 2009 May; 373(1-2):55-61. PubMed ID: 19429288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
